Coherus Biosciences Inc

NASDAQ:CHRS 4:00:00 PM EDT

1.93

-0.09 (-4.46%)

7:10:21 PM EDT: $1.97 +0.04 (+2.05%)

Market Cap (Intraday)	219.04M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$81.7 Million
Adjusted EPS	-$0.25

See more estimates

10-Day MA	$2.12
50-Day MA	$2.35
200-Day MA	$3.12

See more pivots

Coherus Biosciences Inc Stock, NASDAQ:CHRS

333 Twin Dolphin Drive, Suite 600, Redwood City, California 94065

United States of America

Phone: +1.650.649.3530

Number of Employees: 306

http://www.coherus.com

Description

Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and Coherus COMPLETE. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.